We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

A New Strategy in the War on Renal Cell Cancer Hitting Multiple Targets With Limited Collateral Damage

Boris Pasche, MD, PhD
JAMA. 2006;295(21):2537-2538. doi:10.1001/jama.295.21.2537.
Text Size: A A A
Published online


An estimated 38 890 individuals will be diagnosed as having renal cell carcinoma (RCC) in the United States in 2006 and approximately 12 840 patients will die from the disease.1 RCC is the most common malignant lesion of the kidney and accounts for 85% of all renal neoplasms and 3% of all adult malignancies.2 The overall incidence of RCC has increased over the past 20 years from 2% to 4% per year.3 While smoking, hypertension, and obesity have all been associated with RCC risk, smoking has emerged as the most significant risk factor. Cigarette smokers have double the risk of RCC than nonsmokers and pipe and cigar smokers also have an increased risk of the disease.3 RCC occurs most often in individuals aged 50 to 70 years and affects men almost twice as often as women.4 Many patients with this cancer are being diagnosed at an earlier stage due to the increased use of diagnostic testing such as computed tomography and magnetic resonance imaging. In fact, approximately half of RCC cases are now detected because a renal mass is incidentally identified during a radiology examination.5 Yet, one fourth of patients present with advanced disease, including locally invasive or metastatic RCC, and one third of patients with resected localized disease will have a recurrence.6

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

7 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections